Therabron Therapeutics Overview
- Founded
-
2007
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
Therabron Therapeutics General Information
Description
Developer of novel drugs with therapeutic proteins designed to cure respiratory diseases. The company's novel drugs with therapeutic proteins develop a series of recombinant human secretoglobins, enabling patients to access treatments for a range of orphan and more commonplace respiratory diseases impacting people from infancy through adulthood.
Contact Information
Website
www.therabron.com
Formerly Known As
Clarassance
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 9430 Key West Avenue
- Suite 150
- Rockville, MD 20850
- United States
Therabron Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 01-Nov-2018 | 000.00 | Completed | Out of Business | ||
| 7. Later Stage VC | 27-Dec-2016 | 00.000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 6. Later Stage VC (Series B) | 18-Nov-2015 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC | 17-Jun-2014 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 4. Grant | 24-Sep-2012 | 00000 | 00000 | Completed | Startup | |
| 3. Angel (individual) | 17-Sep-2012 | 00000 | 00000 | Completed | Startup | |
| 2. Angel (individual) | 10-Nov-2011 | $315K | $315K | Completed | Startup | |
| 1. Grant | 29-Oct-2010 | $244K | Completed | Startup |
Therabron Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Series A4 | 0,000 | 00.000000 | 000 | 000 | 00 | 000 | 0.000 | |
| Series A3 | 00,000 | 00.000000 | 00 | 00 | 00 | 00 | 0.000 | |
| Series A2 | 89,683 | $0.001000 | $6.3 | $6.3 | 1x | $6.3 | 2.2% | |
| Series A1 | 116,279 | $0.001000 | $2.15 | $2.15 | 1x | $2.15 | 2.85% |
Therabron Therapeutics Patents
Therabron Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9168285-B2 | Recombinant human cc10 protein for treatment of influenza and ebola | Active | 15-Oct-2009 | 00000000000 | |
| US-20150157689-A1 | Recombinant human cc10 protein for treatment of influenza and ebola | Active | 15-Oct-2009 | 00000000000 | |
| AU-2010306840-B2 | Recombinant human cc10 protein for treatment of influenza | Active | 15-Oct-2009 | 0000000000 | |
| AU-2010306840-A1 | Recombinant human cc10 protein for treatment of influenza | Active | 15-Oct-2009 | 0000000000 | |
| CA-2813740-C | Recombinant human cc10 protein for treatment of influenza | Active | 15-Oct-2009 | C07K14/005 |
Therabron Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
